Marta Norton, Empower chief investment strategist, joins 'Squawk Box' to discuss the latest market trends, what to make of the recent pullback, state of market sentiment, impact of AI boom, and more.

Drives efficiency and reliability in Quality Control and Development environments, integrating seamlessly with world-class Empower™ Chromatography Data System (CDS). Mitigates CDS communication errors ...

GREENWOOD VILLAGE, Colo.--(BUSINESS WIRE)--Empower today announced after-tax base earnings of $317 million for the third quarter of 2025, a 10% increase from the same period in 2024. Empower growth ...

Market Momentum and Growth Market adoption has been strong with Empower’s Stock Plan Services (SPS) business on track for a 30% growth rate entering the fourth quarter of 2025. Clients across ...

Save Bayh–Dole’s $2 Trillion Impact on American Innovation Why 2026 Marks the Dawn of Nationwide School Choice The Empower service clearly has a better mousetrap and is serving the needs of both ...

Empower AI has received a U.S. Army contract worth more than $200 million to modernize critical infrastructure across over 80 Army installations to enable real-time analytics, improve energy ...

When Empower entered the Washington, D.C., rideshare market in 2020, it promised to disrupt the status quo by empowering drivers to work for themselves, set their own fares, and collect 100 percent of ...

WASHINGTON — Empower's rideshare drivers were still offering their rates in D.C. on Sunday, even after its CEO told a Superior Court judge that he would end his app's availability inside the District.

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The pharmacy argued in its ...

Explore Empower's wealth management offerings, including investment management through its Personal Strategy program Written By Written by Staff Money Writer, WSJ | Buy Side Molly Grace is a staff ...

MtoZ Biolabs, an integrated chromatography and mass spectrometry (MS) services provider. MtoZ Biolabs offers precise peptide purity analysis leveraging HPLC and LC-MS ...

Cemiplimab plus chemotherapy was found to be consistently effective in treating non-small cell lung cancer (NSCLC) and held up in the EMPOWER-Lung 3 trial. Prior efficacy results for overall survival ...